The global Haemorrhagic Stroke Drugs market size was valued at US$ 2.87 billion in 2024 and is projected to reach US$ 4.16 billion by 2030, at a CAGR of 6.4% during the forecast period 2024-2030. The United States Haemorrhagic Stroke Drugs market size was valued at US$ 962 million in 2024 and is projected to US$ 1.34 billion by 2030, at a CAGR of 5.7% during the forecast period 2024-2030.Downloa..
